Placebo Topical Gel
Sponsors
Watson Pharmaceuticals, Sun Pharmaceutical Industries, Inc., Amirhossein Farahmand, Glia, LLC, PharmaDax Inc.
Conditions
Acne VulgarisChronic Diabetic Foot UlcersChronic Ocular Graft-versus-host DiseaseContact Lens Acute Red EyeContact Lens DiscomfortContact Lens-induced Corneal DisorderContact Lens-induced Corneal Fluorescein StainingDiabetes Mellitus With Periodontal Disease
Phase 1
A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris
CompletedNCT01769664
Start: 2012-09-30End: 2013-08-31Updated: 2014-01-22
Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis
CompletedNCT02335255
Start: 2014-06-27End: 2018-05-15Updated: 2018-09-06
Phase 2
The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®
CompletedNCT02735837
Start: 2015-01-31End: 2016-04-30Updated: 2019-07-05
Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.
CompletedNCT03990051
Start: 2019-10-17End: 2021-11-19Updated: 2025-05-06
Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel
CompletedNCT03994406
Start: 2019-06-27End: 2019-10-30Updated: 2023-03-24
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
NCT04884217
Start: 2021-05-20End: 2021-12-30Target: 80Updated: 2021-05-14
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
TerminatedNCT05276401
Start: 2022-03-11End: 2022-06-15Updated: 2024-01-30